| PACIRA BIOSCIENC. DL-,001 |
| USA |
| Gesundheit |
| US6951271005 / A1H68T |
| 82P (Frankfurt) / PCRX (NASDAQ) |
| FRA:82P, ETR:82P, 82P:GR, NASDAQ:PCRX |
| - |
| http://www.pacira.com/ |
|
Pacira BioSciences Inc. is a pharmaceutical company focused on delivering non-opioid pain management solutions. Its flagship product, EXPAREL, is a long-acting, local analgesic that releases bupivacai..
>Volltext.. |
| 855.07 Mio. EUR |
| 1007.66 Mio. EUR |
| 607.27 Mio. EUR |
| 123.46 Mio. EUR |
| 18.16 Mio. EUR |
| 0.4 EUR |
| 360.33 Mio. EUR |
| 125.04 Mio. EUR |
| 119.83 Mio. EUR |
| 2.3 |
| -2.13% |
| - |
| - |
| - |
| - |
| PACIRA |
| 27.02.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|